HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Taeg Kyu Kwon Selected Research

kahweol

5/2018Kahweol inhibits adipogenesis of 3T3-L1 adipocytes through downregulation of PPARγ.
10/2017The coffee diterpene kahweol enhances sensitivity to sorafenib in human renal carcinoma Caki cells through down-regulation of Mcl-1 and c-FLIP expression.
5/2011Melatonin sensitizes Caki renal cancer cells to kahweol-induced apoptosis through CHOP-mediated up-regulation of PUMA.
6/2010The coffee diterpene kahweol sensitizes TRAIL-induced apoptosis in renal carcinoma Caki cells through down-regulation of Bcl-2 and c-FLIP.
11/2009The coffee diterpene kahweol induces apoptosis in human leukemia U937 cells through down-regulation of Akt phosphorylation and activation of JNK.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Taeg Kyu Kwon Research Topics

Disease

158Neoplasms (Cancer)
06/2022 - 08/2002
50Renal Cell Carcinoma (Grawitz Tumor)
12/2021 - 07/2005
36Inflammation (Inflammations)
12/2021 - 06/2004
25Carcinoma (Carcinomatosis)
01/2022 - 01/2007
25Breast Neoplasms (Breast Cancer)
12/2021 - 12/2006
24Kidney Neoplasms (Kidney Cancer)
08/2020 - 11/2005
19Glioma (Gliomas)
11/2020 - 09/2007
19Leukemia
06/2019 - 08/2002
17Carcinogenesis
01/2022 - 02/2004
17Neoplasm Metastasis (Metastasis)
01/2022 - 06/2003
14Hepatocellular Carcinoma (Hepatoma)
05/2019 - 06/2003
12Hypersensitivity (Allergy)
08/2020 - 11/2007
12Colonic Neoplasms (Colon Cancer)
09/2011 - 02/2004
10Anaphylaxis (Anaphylactic Shock)
06/2020 - 05/2010
9Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 02/2004
7Atopic Dermatitis (Atopic Eczema)
05/2021 - 09/2015
5Lung Neoplasms (Lung Cancer)
11/2018 - 12/2004
4Obesity
05/2022 - 05/2018
4Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 03/2008
4Head and Neck Neoplasms (Head and Neck Cancer)
01/2017 - 01/2009
4Prostatic Neoplasms (Prostate Cancer)
10/2016 - 02/2010
3Melanoma (Melanoma, Malignant)
06/2020 - 08/2002
3Asthma (Bronchial Asthma)
06/2020 - 09/2015
3Hypothermia
01/2019 - 09/2015
3Rheumatoid Arthritis
08/2017 - 09/2007
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 01/2015

Drug/Important Bio-Agent (IBA)

38Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2021 - 10/2005
33LigandsIBA
12/2021 - 02/2005
23Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2005
16CaspasesIBA
05/2022 - 08/2002
15Pharmaceutical PreparationsIBA
01/2022 - 12/2007
14Immunoglobulin E (IgE)IBA
05/2021 - 02/2008
14Reactive Oxygen Species (Oxygen Radicals)IBA
10/2019 - 02/2006
12NF-kappa B (NF-kB)IBA
09/2011 - 02/2004
11FlavonoidsIBA
09/2020 - 09/2007
11Caspase 3 (Caspase-3)IBA
03/2020 - 08/2002
10Messenger RNA (mRNA)IBA
01/2022 - 04/2005
10CurcuminIBA
01/2018 - 04/2003
9PhytochemicalsIBA
12/2020 - 12/2014
9SurvivinIBA
08/2020 - 09/2007
9Death Domain ReceptorsIBA
09/2019 - 02/2006
9withaferin AIBA
01/2015 - 12/2008
8p38 Mitogen-Activated Protein KinasesIBA
12/2021 - 11/2007
8CytokinesIBA
08/2021 - 02/2008
8CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA
04/2021 - 08/2010
7Biological ProductsIBA
08/2020 - 08/2006
7Histamine (Histamine Dihydrochloride)FDA Link
08/2020 - 10/2008
6MelatoninIBA
01/2022 - 10/2010
6DNA (Deoxyribonucleic Acid)IBA
06/2020 - 04/2005
6Apoptosis Regulatory ProteinsIBA
12/2019 - 04/2011
6DiterpenesIBA
10/2019 - 11/2009
6TNF-Related Apoptosis-Inducing LigandIBA
09/2019 - 02/2006
6Protein Kinase CIBA
04/2012 - 08/2002
6CalciumIBA
09/2011 - 11/2007
6ResveratrolIBA
04/2010 - 03/2004
5Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2022 - 11/2008
5Small Interfering RNA (siRNA)IBA
01/2022 - 01/2008
5EnzymesIBA
12/2021 - 04/2006
5Glucose (Dextrose)FDA LinkGeneric
12/2021 - 11/2008
5AntioxidantsIBA
10/2021 - 10/2010
5hispidulinIBA
05/2021 - 09/2018
5Proteasome Endopeptidase Complex (Proteasome)IBA
08/2020 - 06/2004
5Matrix Metalloproteinases (MMPs)IBA
06/2020 - 06/2003
5MicroRNAs (MicroRNA)IBA
07/2019 - 07/2014
5TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
11/2018 - 11/2006
5kahweolIBA
05/2018 - 11/2009
5cathepsin SIBA
01/2018 - 09/2016
5p-Methoxy-N-methylphenethylamineIBA
05/2015 - 05/2010
5rottlerinIBA
04/2012 - 11/2008
5Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2011 - 02/2004
5QuercetinIBA
02/2010 - 02/2003
51-dodecylpyridoxal (PLD)IBA
02/2008 - 04/2002
4Cytochromes c (Cytochrome c)IBA
01/2022 - 03/2008
4fisetinIBA
01/2022 - 10/2008
4Antineoplastic Agents (Antineoplastics)IBA
09/2021 - 11/2006
4Immunoglobulin G (IgG)IBA
05/2021 - 01/2016
4Cyclin-Dependent Kinases (cdk Proteins)IBA
04/2021 - 01/2009
4Anti-Allergic Agents (Antiallergic Agents)IBA
10/2020 - 02/2008
4Transcription Factors (Transcription Factor)IBA
09/2020 - 11/2009
4Protein Isoforms (Isoforms)IBA
04/2019 - 12/2007
4OvalbuminIBA
01/2019 - 09/2015
4esculetinIBA
06/2018 - 03/2008
4LipopolysaccharidesIBA
11/2017 - 06/2004
4CoffeeFDA Link
10/2017 - 11/2009
4acetamideIBA
01/2015 - 01/2009
4CCAAT-Enhancer-Binding ProteinsIBA
04/2010 - 11/2007
4Phospholipase DIBA
02/2008 - 04/2002
3LipidsIBA
12/2021 - 04/2018
3Dinitrochlorobenzene (DNCB)IBA
05/2021 - 06/2018
3Therapeutic UsesIBA
10/2020 - 09/2007
3UbiquitinIBA
08/2020 - 06/2004
3Lysine (L-Lysine)FDA Link
06/2020 - 04/2019
3CarcinogensIBA
05/2020 - 05/2003
3TriterpenesIBA
12/2018 - 10/2015
3CalpainIBA
01/2018 - 08/2002
3Mifepristone (RU 486)FDA Link
02/2016 - 03/2012
3salvinIBA
01/2016 - 09/2014

Therapy/Procedure

19Therapeutics
09/2021 - 11/2006
9Oral Administration
12/2021 - 02/2014
4Drug Therapy (Chemotherapy)
01/2019 - 10/2005